Navigation Links
Ulthera Launches New Aesthetic Clinical Indication - Treatment of the Decolletage - in Asia

MESA, Ariz., July 3, 2012 /PRNewswire/ -- Ulthera, Inc. – a global, growth-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – today announced the commercial availability of the Ulthera System in select Asian countries to non-invasively treat the skin on the chest area – also known as the decolletage or decollete.

The Ulthera System – which combines time-honored ultrasound imaging with focused ultrasound therapy in a procedure known as Ultherapy – has been used in many Asian countries to treat the face and neck since 2008. The new decolletage indication will utilize the System's same technology to encourage the natural formation of collagen and elastin on the chest – just as with the face and neck – giving it the ability to lift tissue. For the decolletage, this lifting effect can result in a gradual reduction of chest wrinkles over three months, with continued improvement possible for up to six months post-procedure.

"The global demand for safe and effective non-invasive procedures is rapidly growing. This is why Ulthera has made significant investments in clinical development to qualify our ultrasound platform technology for a host of medical and off-face aesthetic indications," said Matthew Likens, president and CEO of Ulthera. "Launching the decolletage treatment in Asia is just the tip of the iceberg. We anticipate an exciting second half of 2012 with even more international indications on the horizon as well as additional countries where System clearance is anticipated."

Starting July 3, 2012, Ulthera will be initiating a multi-country tour in Asia to introduce the new clinical indication to practitioners. For more information on the tour, contact Candice Wong at or +852-9650-1505.

The Ulthera System is cleared by the U.S. FDA for use in a non-invasive treatment of the face to lift the eyebrow to achieve a desired aesthetic effect. The new clinical indication to treat the decolletage will not be commercially available in all Asian countries, including those that do not currently offer Ultherapy as well as Singapore and Hong Kong where the System is only cleared to treat the face.  

About Ulthera
Ulthera, Inc. is a global, growth-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. The first application for Ultherapy® – the procedure enabled by the System – is a non-invasive treatment of the face to achieve a brow lift. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top tier venture capital firms, New Enterprise Associates and Apposite Capital. For more information, visit


SOURCE Ulthera, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bulgaria Launches Development of National Hepatitis Plan
2. Fidelitas Launches Unique Methadone Documentation and Dispensing System in Canada
3. Mylan Launches Thiamine Hydrochloride Injection
4. PeriGen, Inc. Launches Consumer Safety Campaign to Raise Awareness of Dangerous Birth Complication
5. Varian X-Ray Products Business Launches On-Line Product Finder for Customers
6. Konica Minolta Sensing America Launches Spanish Website in Support of Growing Demand In Latin American Countries
7. The Michael J. Fox Foundation Launches The $14 Million-Edmond J. Safra Core Programs for PD Research
8. Lifescript Launches New Online Asthma Health Center
9. AUA Foundation Launches Campaign to Address Stigma of Overactive Bladder
10. Smith & Nephew launches two plating systems for foot and ankle surgeons at AOFAS annual meeting in San Diego
11. Lilly Diabetes Launches 8th Annual Diabetes Summer Camp Tour With Olympian Kris Freeman
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015   Nuance Communications, Inc. ... National Decision Support Company (NDSC) today jointly announced ... collaboration capabilities that utilize the American College of Radiology,s ... provider organizations to comply with current and emerging ... --> By combining clinical decision support, ...
(Date:11/30/2015)... , Nov. 30, 2015  Novartis will demonstrate the ... 57 th American Society of Hematology (ASH) Annual ... myelomas as well as supportive care, including key findings ... personalized cell therapies. The ASH Annual Meeting will be ... . Novartis Oncology . "We will be ...
(Date:11/30/2015)... Israel , Nov. 30, 2015  OticPharma, Ltd., ... and developing innovative therapies for ear, nose, and throat ... A. Katkin as chairman of the company,s board ... executive officer for OticPharma, Ltd.  "Keith brings a wealth ... will be able to share this experience and provide ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag Specialties, Inc. (BSI) ... for the Nutraceutical Specialties products into oral solid dosage in the over the ... “We are pleased to announce our expanded distribution agreement with ASI.” said Steve ...
(Date:11/30/2015)... ... November 30, 2015 , ... An inventor from Charlottesville, Va., is ... "My last baby had high blood pressure due to loud noises," she said, "so ... babies from noise pollution as well as radio waves and microwaves." , The baby ...
(Date:11/30/2015)... ... November 30, 2015 , ... Since its ... specializing in independent living, assisted living and all other retirement options. Support for ... awareness and research remains a top priority. , So it’s no surprise ...
(Date:11/30/2015)... New York, New York (PRWEB) , ... November 30, 2015 , ... ... at the Greater New York Dental Meeting. Their Ecosystem empowers dentists to make complex ... Dentists who visit the booth will receive a free fee survey with 10 procedures ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... of DataTrade Solutions Inc., a Healthcare IT consulting, development and support company. The ... and technical experience available within DataTrade to extend the services currently provided by ...
Breaking Medicine News(10 mins):